EXACT Sciences Corp.
-
Ticker
EXAS
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 1001-5000 Employees
- Based in Madison, Wisconsin
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing a molecular diagnostic screening technology for the early detection and prevention of colorectal pre-cancer and cancer. The company develops Cologuard, a stool-based DNA colorectal cancer screening test that is designed to detect each of the four stages of colorectal cancer, as well as pre-cancerous lesions.
REPORT RATINGS
4.8 / 5.0 (67)
EXACT Sciences Corp. reports have an aggregate usefulness score of 4.8 based on 67 reviews.
EXACT Sciences Corp.
Most Recent Responsibility Report
MOST RECENT
2023 ESG Report
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived EXACT Sciences Corp. Sustainability Report, EXACT Sciences Corp. Corporate Social Responsibility Report, EXACT Sciences Corp. CSR Report, EXACT Sciences Corp. Corporate Responsibility, EXACT Sciences Corp. CR Report, EXACT Sciences Corp. Citizenship Report, EXACT Sciences Corp. ESG Report, and EXACT Sciences Corp. Environmental Report online.